Renaissance Venture Capital Fund
9
30M
8
0.64
1
0.11
2
- Stages of investment
- Areas of investment
Summary
In 2008 was created Renaissance Venture Capital Fund, which is appeared as VC. The leading representative office of defined VC is situated in the Ann Arbor. The venture was found in North America in United States.
The overall number of key employees were 1.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Renaissance Venture Capital Fund, startups are often financed by Arboretum Ventures, eLab Ventures, Wolverine Venture Fund. The meaningful sponsors for the fund in investment in the same round are Frazier Healthcare Partners, Arboretum Ventures, Adams Street Partners. In the next rounds fund is usually obtained by Frazier Healthcare Partners, Arboretum Ventures, Adams Street Partners.
The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2017.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Service Industry. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Cirius Therapeutics, Millendo Therapeutics, ArborMetrix. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.64
- Follow on index
- 0.11
- Investments by industry
- Biotechnology (5)
- Health Care (5)
- Medical Device (3)
- Health Diagnostics (3)
- Therapeutics (2) Show 17 more
- Investments by region
-
- United States (9)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 0.89
- Avg. company exit year
- 11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Strata Oncology | 28 Jul 2021 | Biotechnology, Health Care, Health Diagnostics, Genetics, Medical Device | Late Stage Venture | 90M | United States, Ann Arbor, Michigan |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.